Seuraa
Mark Blaskovich
Mark Blaskovich
Group Leader, Institute for Molecular Bioscience, The University of Queensland
Vahvistettu sähköpostiosoite verkkotunnuksessa uq.edu.au - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Quinolone antibiotics
TDM Pham, ZM Ziora, MAT Blaskovich
Medchemcomm 10 (10), 1719-1739, 2019
7122019
Antibiotics in the clinical pipeline in 2013
MS Butler, MA Blaskovich, MA Cooper
The Journal of antibiotics 66 (10), 571-591, 2013
5792013
Unusual amino acids in medicinal chemistry
MAT Blaskovich
Journal of medicinal chemistry 59 (24), 10807-10836, 2016
5302016
Metal complexes as a promising source for new antibiotics
A Frei, J Zuegg, AG Elliott, M Baker, S Braese, C Brown, F Chen, ...
Chemical science 11 (10), 2627-2639, 2020
4462020
Antibiotics in the clinical pipeline at the end of 2015
MS Butler, MAT Blaskovich, MA Cooper
The Journal of antibiotics 70 (1), 3-24, 2017
4252017
Antimicrobial silver in medicinal and consumer applications: a patent review of the past decade (2007–2017)
W Sim, RT Barnard, MAT Blaskovich, ZM Ziora
Antibiotics 7 (4), 93, 2018
4122018
Metals to combat antimicrobial resistance
A Frei, AD Verderosa, AG Elliott, J Zuegg, MAT Blaskovich
Nature Reviews Chemistry 7 (3), 202-224, 2023
3622023
Glycopeptide antibiotics: back to the future
MS Butler, KA Hansford, MAT Blaskovich, R Halai, MA Cooper
The Journal of antibiotics 67 (9), 631-644, 2014
3492014
Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides
IA Edwards, AG Elliott, AM Kavanagh, J Zuegg, MAT Blaskovich, ...
ACS infectious diseases 2 (6), 442-450, 2016
2672016
Developments in glycopeptide antibiotics
MAT Blaskovich, KA Hansford, MS Butler, ZG Jia, AE Mark, MA Cooper
ACS infectious diseases 4 (5), 715-735, 2018
2662018
The antimicrobial potential of cannabidiol
MAT Blaskovich, AM Kavanagh, AG Elliott, B Zhang, S Ramu, M Amado, ...
Communications biology 4 (1), 7, 2021
2282021
Helping chemists discover new antibiotics
MAT Blaskovich, J Zuegg, AG Elliott, MA Cooper
ACS infectious diseases 1 (7), 285-287, 2015
2232015
Silver bullets: A new lustre on an old antimicrobial agent
JS Möhler, W Sim, MAT Blaskovich, MA Cooper, ZM Ziora
Biotechnology advances 36 (5), 1391-1411, 2018
1842018
Nitroimidazoles: molecular fireworks that combat a broad spectrum of infectious diseases
CW Ang, AM Jarrad, MA Cooper, MAT Blaskovich
Journal of medicinal chemistry 60 (18), 7636-7657, 2017
1672017
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
AG Elliott, JX Huang, S Neve, J Zuegg, IA Edwards, AK Cain, CJ Boinett, ...
Nature communications 11 (1), 3184, 2020
1492020
Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B
A Gallardo-Godoy, C Muldoon, B Becker, AG Elliott, LH Lash, JX Huang, ...
Journal of medicinal chemistry 59 (3), 1068-1077, 2016
1482016
Protein-inspired antibiotics active against vancomycin-and daptomycin-resistant bacteria
MAT Blaskovich, KA Hansford, Y Gong, MS Butler, C Muldoon, JX Huang, ...
Nature communications 9 (1), 22, 2018
1402018
Antibiotics in the clinical pipeline as of December 2022
MS Butler, IR Henderson, RJ Capon, MAT Blaskovich
The Journal of Antibiotics 76 (8), 431-473, 2023
1342023
Statistical evaluation of cow-dung derived activated biochar for phenol adsorption: Adsorption isotherms, kinetics, and thermodynamic studies
M Jain, SA Khan, A Sahoo, P Dubey, KK Pant, ZM Ziora, MAT Blaskovich
Bioresource Technology 352, 127030, 2022
1292022
Fluorescent antibiotics: new research tools to fight antibiotic resistance
MRL Stone, MS Butler, W Phetsang, MA Cooper, MAT Blaskovich
Trends in biotechnology 36 (5), 523-536, 2018
1292018
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20